Physician and pharmacist with over 30 years of strategic and operational experience in global Clinical Research & Development within leading pharmaceutical companies. Proven expertise in planning and executing complex phase 2 and 3 clinical development programs and large-scale phase 4 studies.

Most recently Medical Lead in a global development project covering a new treatment for anemia of CKD with oversight of trials, safety, and regulatory approvals, leading to EU approval in 2021. Since 2022 serving as Chief Medical Officer for Guard Therapeutics, a Swedish biotech company focused on development of novel therapies targeting kidney disease.